ArticlePediatric cardiology2026
Survival and Associated Factors for Mortality Among Infants with Tetralogy of Fallot in a Middle-Income Country.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tetralogy of Fallot (TOF) is the most common cyanotic heart disease, yet population-based survival data from low- and middle-income countries remain limited. This study evaluated survival up to 15 years of age and identified factors associated with mortality in Malaysia. This population-based cohort included all children with TOF registered in the Paediatric Cardiology Clinical Information System who were born between 2006 and 2022. Clinical characteristics and outcomes were analysed. Kaplan-Meier analysis estimated survival probabilities at 1, 5, 10, and 15 years, while Cox proportional hazards regression identified factors associated with mortality. A total of 285 TOF patients were included, with a median age at diagnosis of 8 days and a mean birth weight of 2.8 kg. Of these, 67 (24%) had an associated syndrome or non-cardiac malformation (NCM), 94 (33%) were symptomatic neonates, and 62 (22%) required staged repair. The overall mortality rate was 14%, with a median age at death of 14 months. The estimated survival rate was 94% at 1 year, 87% at 5 years, and 86% at both 10 and 15 years. Independent factors for mortality included low birth weight (aHR 3.4, 95% Confidence interval [CI] 1.6-7.2), an associated syndrome/NCM (aHR 3.7, 95% CI 1.9-7.6), and symptomatic neonates (aHR 4.4, 95% CI 1.7-11.1). Eight in 10 TOF patients survived to 15 years. Poorer outcomes were observed in low-birth-weight infants, non-isolated TOF, and symptomatic neonates, underscoring the need for improved perinatal diagnosis, neonatal care, and targeted management of high-risk infants.
Indexed as
Identifiers
42803921What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.